Search
Search Results
-
MYCOPLASMA AND CANDIDA-ASSOCIATED PNEUMONIA IN CHILDREN
Community-acquired pneumonia remains one of the leading causes of morbidity in children. In recent years, atypical pathogens such as Mycoplasma pneumoniae and opportunistic fungi of the genus Candida have gained increasing attention, particularly in cases with prolonged or severe clinical course. Following the widespread introduction of childhood pneumococcal conjugate vaccines (PCVs), a significant impact on pneumonia mortality in children under five years of age has been reported. It is still unknown whether PCVs are expected to reduce pneumonia burden in younger children, particularly ≤2 months of age, as current evidence on the role of S. pneumoniae in pneumonia etiology in this age group is scarce.